Feeley Kevin, CFO, reported an open-market or private sale at GeneDx Holdings Corp. involving 275.000000 shares for an estimated $21582.11. Reported holdings after the transaction were 2950.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
CHIEF FINANCIAL OFFICER
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy ta…
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.48 to $78.5983 per share, inclusive. The Reporting Person underta…
25% of the underlying shares each vested on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued servi…
0 other filings
0 recent txs